GP-TCM RA Newsletter March 2019

Season’s greetings from London, Mons and Taichung!

Highlights of the GP-TCM RA Newsletter March 2019:

• Cancer in China 2019
• Biopharma dealmaking in 2018
• China tightens rules on gene editing
• Countdown Global Mental Health 2030
• Taming the fire of nephrotoxic botanicals
• Unstable genomes promote inflammation
• NIH queries on foreign ties rattle universities
• Dietary supplement regulation: FDA’s bitter pill
• Invitation from Lancet, WJTCM and other journals
• A review on wound healing activity of herbal drugs
• Proteomics identifies new cancer therapeutic targets
• Four N Engl J Med papers on genome and DNA editing
• Paul Nurse on Brexit: ‘UK is sleepwalking into a disaster’
• China’s trading day is starting to influence global markets
• Major Events in the Life Course of New Drugs, 2000–2016
• The 48th GP-TCM RA BoD meeting was held on 1st March
• Develop a Good Publication Network for Clinical Study of TCM
• 101 ideas on the Future of Research and Innovation in Europe

• Horizon 2020: Update on Health-related Funding Opportunities
• Target-Specific Precision of CRISPR-Mediated Genome Editing
• 2018 FDA approvals hit all time high – but average value slips again
• An Introduction and Plans of the Regulatory Aspects Interest Group
• Mechanisms of Anti-arrhythmic Chinese herbal medicine unraveled
• American and Chinese Scientists Call for International Collaboration
• To move research from quantity to quality, go beyond good intentions
• The 18th Meeting of CGCM will be held in Shanghai on August 8 – 10
• Incidence and Etiology of Drug-Induced Liver Injury in Mainland China
• Chinese Academy of Sciences to strengthen international cooperation
• Hong Kong has established the standards for 299 Chinese materia medica
• 14 held accountable, time-honored company punished for expired products
• The new isolationism takes us back to the Seventies. This is not a good thing
• A review on herbal drugs used for management and treatment of hypertension
• The 7th Annual Meeting of GP-TCM RA will be held in South Korea, July 9 –11
• Advancing Computational Toxicology in the Big Data Era by Artificial Intelligence
• The 2nd Lecture Contest on the Natural History of Materia Medica Held in BUCM

You have received this e-mail because you have previously agreed to receive the GP-TCM RA Newsletters. If you no longer want to receive e-mails from us or if you wish to recommend anyone as a recipient of our monthly newsletters, please contact our secretariat: [email protected].  Happy reading!

Best wishes,

Qihe Xu, London; Pierre Duez, Mons; and Yuan-Shiun Chang, Taichung.

http://www.gp-tcm.org/